HMMR was originally identified as the receptor for hyaluronan (HA), a component of extracellular matrix, and it is frequently upregulated in various cancer types, including colon cancer, bladder cancer, prostate cancer, and liver cancer [83, 92–95]. Here, HMMR is linked to urinary bladder cancer.